• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

NASDAQ

Second Sight facing Nasdaq delisting

October 5, 2020 By Sean Whooley

Second Sight Medical (NSDQ:EYES) announced that it received a letter from the Nasdaq market confirming that it may face delisting. The Sylmar, Calif.-based developer and manufacturer of implantable visual prosthetics for blind individuals received the letter confirming that its common stock had closed below the $1 per share minimum required for continued listing for 30 consecutive […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Wall Street Beat Tagged With: NASDAQ, Second Sight

Acutus Medical launches IPO on Nasdaq

August 6, 2020 By Sean Whooley

Cardiac mapping technology developer Acutus Medical announced that it priced its initial public offering on the Nasdaq market. The Carlsbad, Calif.-based company is offering 8,823,529 shares of its common stock at $18 per share, with gross proceeds expected to come in at approximately $158.8 million. Acutus Medical’s shares are expected to begin trading today (Aug.6, […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Funding Roundup, Initial Public Offering (IPO), Vascular, Wall Street Beat Tagged With: Acutus Medical, NASDAQ

Hancock Jaffe Labs in danger of losing NASDAQ listing

March 27, 2020 By Sean Whooley

NASDAQ has warned Hancock Jaffe Laboratories (NSDQ:HJLI) that it is in danger of being delisted, but the company said in an SEC filing today that it intends to return to compliance. The warning, issued last week, said Hancock Jaffe did not have the minimum of $2.5 million in stockholders’ equity to merit its listing on the […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: hancockjaffelabs, NASDAQ

Pavmed back in NASDAQ compliance

January 13, 2020 By Nancy Crotti

Pavmed (NSDQ:PAVM) said today that it has received formal notice from NASDAQ that it has returned to compliance with the stock exchange’s listing rule after 10 consecutive days with a closing bid price of at least $1 per share. NASDAQ warned the company in November that it was in danger of delisting due to poor […]

Filed Under: Business/Financial News, Catheters, Featured, Surgical, Wall Street Beat Tagged With: NASDAQ, Pavmed

Pavmed threatened with stock exchange delisting

November 4, 2019 By Nancy Crotti

Pavmed (NSDQ:PAVM) is in danger of losing its listing on the NASDAQ exchange, according to a report filed with the Securities & Exchange Commission. In August last year, the FDA group reviewing Pavmed’s 510(k) application for its CarpX minimally invasive carpal tunnel release device asked the company to resubmit the application because the group hadn’t reached […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: FDA, NASDAQ, Pavmed, Securities & Exchange Commission (SEC)

Invuity closes $47.8m IPO

June 19, 2015 By Fink Densford

Invuity (NSDQ:IVTY) said it closed its initial public offering, raising approximately $47.8 million by offering 4.6 million shares at $12 per share. Leerink Partners, Piper Jaffray and Stifel were book-runners for the offering, with William Blair acting as co-manager, the company said. The IPO’s underwriters exercised a 600,000-share over-allotment, the San Francisco, Calif.-based surgical illumination device company […]

Filed Under: Business/Financial News, Initial Public Offering (IPO), Surgical Tagged With: Invuity, Laser/Light-based Devices, NASDAQ

UPDATE: Invuity prices IPO at $12 per share, under the range

June 12, 2015 By Fink Densford

Invuity yesterday priced its initial public offering at $12 a share, under the range the advanced surgical lighting maker set earlier in June, looking to raise $48 million. Invuity shares were set to begin trading today under the “IVTY” symbol on the NASDAQ exchange, the company said, but plans for opening have been delayed until […]

Filed Under: Business/Financial News, Initial Public Offering (IPO), Surgical Tagged With: Invuity, Laser/Light-based Devices, NASDAQ

InVivo hits the NASDAQ exchange

April 17, 2015 By Val Kennedy Leave a Comment

InVivo shares to trade Friday on Nasdaq Capital Market

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: InVivo Therapeutics, NASDAQ

InVivo Therapeutics readies reverse split ahead of NASDAQ listing

March 24, 2015 By Brad Perriello Leave a Comment

InVivo Therapeutics readies reverse split ahead of NASDAQ listing

Filed Under: News Well, Regenerative Medicine, Spine, Wall Street Beat Tagged With: InVivo Therapeutics, NASDAQ

Intuitive Surgical cleared by FDA for single-site da Vinci Sp robotic surgery system | Medtech regulatory news for the week of Apr. 28, 2014

April 29, 2014 By MassDevice Leave a Comment

FDA clears Intuitive Surgical's single-site da Vinci Sp robotic surgery system

April 22, 2014 by Brad Perriello

Filed Under: Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: Intuitive Surgical, Judge Rotenberg Center, NASDAQ, Ulthera Inc.

Ulthera registers for $86M IPO

April 22, 2014 By Brad Perriello Leave a Comment

Ulthera registers for $86M IPO

Ulthera filed for a U.S. initial public offering yesterday, saying it hopes to raise as much as $86 million when it debuts on the NASDAQ stock exchange.

Mesa, Ariz.-based Ulthera makes an ultrasound device, which is designed to use the body’s natural healing process to non-invasively lift and tighten loose skin on the neck and under the chin.

Filed Under: Cosmetic/Aesthetic, Initial Public Offering (IPO), News Well, Regulatory/Compliance Tagged With: NASDAQ, Ulthera Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS